Possibilities for implementing of anti-fibrotic and anti-inflammatory effects of metabolic therapy in acute alcoholic disorders under experimental conditions
DOI:
https://doi.org/10.14739/2310-1210.2022.4.255267Keywords:
alcoholic liver diseases, rats, metabolic therapy, animal experimentation, IGF-1, TGF-β1, glutargin, corvitin, cell cycleAbstract
The aim of the work was to study antifibrotic and anti-inflammatory effects of metabolic therapy and mechanisms of regeneration in acute alcoholic liver damage (AALD) in rats under experimental conditions.
Materials and methods. The experiment involved 66 white non-linear male rats with a mass of 120–130 g, which were divided into 5 groups: 1 – intact animals (n = 10); 2 – animals with AALD (n = 20), 3 – animals (n = 12) with AALD and intraperitoneally injected with Corvitin, 4 – animals (n = 12) with AALD and injected with Glutargin, 5 – аnimals with AALD (n = 12) and injected with Corvitin and Glutargin. The pro-inflammatory cytokines and cell cycle phases were analyzed.
Results. The level of IGF-1 was significantly 24.1 % higher in group 2 compared to the control. In animals of group 3, the level of IGF-1 was 20.2 % decreased compared with group 2. The level of IGF-1 was significantly 9.7 % decreased in group 5 animals compared with group 2. There was a 31.6% increase in the level of TGF-β in animals of group 2 in comparison with the control ones. The level of TGF-β was 22.8 % decreased in group 3 compared with group 2. In group 5 animals, the value was 12.0 % lower than in group 2. The percentage of cell nuclei in the presynthetic phase in group 2 rats was 8.3 % higher than in controls. In animals of group 2, the number of cell nuclei in the phase of DNA synthesis were 33.3 % larger than in group 1. The rate of DNA fragmentation in AALD exceeded the corresponding value in control group by 27.5 %.
Conclusions. AALD was accompanied by an increase in the serum IGF-1 and TGF-β in animals. The administration of corvitin decreased the level of IGF-1 in rats with AALD, and the use of glutargine mainly decreased the level of TGF-β. Combined use of the drugs did not show significant effectiveness. Compensatory regeneration mechanisms were activated in AALD processes and apoptotic cell death was evidenced by the increased indicators of nuclear DNA fragmentation.
References
Carpenter, R. W., Treloar Padovano, H., Emery, N. N., & Miranda, R., Jr (2019). Rate of alcohol consumption in the daily life of adolescents and emerging adults. Psychopharmacology, 236(11), 3111-3124. https://doi.org/10.1007/s00213-019-05262-8
Xi, B., Veeranki, S. P., Zhao, M., Ma, C., Yan, Y., & Mi, J. (2017). Relationship of Alcohol Consumption to All-Cause, Cardiovascular, and Cancer-Related Mortality in U.S. Adults. Journal of the American College of Cardiology, 70(8), 913-922. https://doi.org/10.1016/j.jacc.2017.06.054
Crabb, D. W., Im, G. Y., Szabo, G., Mellinger, J. L., & Lucey, M. R. (2020). Diagnosis and Treatment of Alcohol-Associated Liver Diseases: 2019 Practice Guidance From the American Association for the Study of Liver Diseases. Hepatology, 71(1), 306-333. https://doi.org/10.1002/hep.30866
Mustafina, Н. M., Starchenko, I. I., Koka, V. М., & Lukachina, Ye. I. (2020). Modern views on the functional morphology and reparative properties of the liver. Visnyk problem biolohiyi i medytsyny. Vypusk 2 (156) (in Ukrainian) https://doi.org/10.29254/2077-4214-2020-2-156-43-48
Li, W., Li, L., & Hui, L. (2020). Cell Plasticity in Liver Regeneration. Trends in cell biology, 30(4), 329-338. https://doi.org/10.1016/j.tcb.2020.01.007
Gilgenkrantz, H., & Collin de l'Hortet, A. (2018). Understanding Liver Regeneration: From Mechanisms to Regenerative Medicine. The American journal of pathology, 188(6), 1316-1327. https://doi.org/10.1016/j.ajpath.2018.03.008
Campollo, O. (2019). Alcohol and the Liver: The Return of the Prodigal Son. Annals of hepatology, 18(1), 6-10. https://doi.org/10.5604/01.3001.0012.7854
Hosseini, N., Shor, J., & Szabo, G. (2019). Alcoholic Hepatitis: A Review. Alcohol and alcoholism, 54(4), 408-416. https://doi.org/10.1093/alcalc/agz036
Ma, H. Y., Yamamoto, G., Xu, J., Liu, X., Karin, D., Kim, J. Y., Alexandrov, L. B., Koyama, Y., Nishio, T., Benner, C., Heinz, S., Rosenthal, S. B., Liang, S., Sun, M., Karin, G., Zhao, P., Brodt, P., Mckillop, I. H., Quehenberger, O., Dennis, E., … Kisseleva, T. (2020). IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease. Journal of hepatology, 72(5), 946-959. https://doi.org/10.1016/j.jhep.2019.12.016
Singal, A. K., Louvet, A., Shah, V. H., & Kamath, P. S. (2018). Grand Rounds: Alcoholic Hepatitis. Journal of hepatology, 69(2), 534-543. https://doi.org/10.1016/j.jhep.2018.05.001
Yang, H., Yang, T., Heng, C., Zhou, Y., Jiang, Z., Qian, X., Du, L., Mao, S., Yin, X., & Lu, Q. (2019). Quercetin improves nonalcoholic fatty liver by ameliorating inflammation, oxidative stress, and lipid metabolism in db/db mice. Phytotherapy research: PTR, 33(12), 3140-3152. https://doi.org/10.1002/ptr.6486
Abdelhalim, M., Qaid, H. A., Al-Mohy, Y., & Al-Ayed, M. S. (2018). Effects of quercetin and arginine on the nephrotoxicity and lipid peroxidation induced by gold nanoparticles in vivo. International journal of nanomedicine, 13, 7765-7770. https://doi.org/10.2147/IJN.S183281
Simon, T. G., Roelstraete, B., Khalili, H., Hagström, H., & Ludvigsson, J. F. (2021). Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort. Gut, 70(7), 1375-1382. https://doi.org/10.1136/gutjnl-2020-322786
Wang, W., Wang, C., Xu, H., & Gao, Y. (2020). Aldehyde Dehydrogenase, Liver Disease and Cancer. International journal of biological sciences, 16(6), 921-934. https://doi.org/10.7150/ijbs.42300
Xu, J., Wang, X., Chen, J., Chen, S., Li, Z., Liu, H., Bai, Y., & Zhi, F. (2020). Embryonic stem cell-derived mesenchymal stem cells promote colon epithelial integrity and regeneration by elevating circulating IGF-1 in colitis mice. Theranostics, 10(26), 12204-12222. https://doi.org/10.7150/thno.47683
Adamek, A., & Kasprzak, A. (2018). Insulin-Like Growth Factor (IGF) System in Liver Diseases. International journal of molecular sciences, 19(5), 1308. https://doi.org/10.3390/ijms19051308
Liu, Z., Han, T., Werner, H., Rosen, C. J., Schaffler, M. B., & Yakar, S. (2018). Reduced serum IGF-1 associated with hepatic osteodystrophy is a main determinant of low cortical but not trabecular bone mass. Journal of bone and mineral research, 33(1), 123-136. https://doi.org/10.1002/jbmr.3290
Rykalo, N. A., Semenchuk, S. A., Ivanytsia, A. O., & Mikhailivna, O. Y. (2020). Сoncentration of IGF-1 and TGF-β in the blood plasma of rats with chronic toxic hepatitis and its correction with lisinopril. Azerbaydzhanskiy meditsinskiy zhurnal, (5), 89-95. https://doi.org/10.34921/amj.2020.4.013
Frangogiannis N. (2020). Transforming growth factor-β in tissue fibrosis. The Journal of experimental medicine, 217(3), e20190103. https://doi.org/10.1084/jem.20190103
Dewidar, B., Meyer, C., Dooley, S., & Meindl-Beinker, A. N. (2019). TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019. Cells, 8(11), 1419. https://doi.org/10.3390/cells8111419
Pivtorak, V. I., Bulko, M. P., & Kostyuk, G. Ya. (2018). Osoblyvosti klitynnoho tsyklu klityn pechinky pislia rezektsii [Features of the cell cycle of liver cells after partial hepatectomy]. Visnyk problem biolohii i medytsyny, (4), 287-290. [in Ukrainian]. http://dx.doi.org/10.29254/2077-4214-2018-4-2-147-287-290
Anthony, B., Zhou, F. C., Ogawa, T., Goodlett, C. R., & Ruiz, J. (2008). Alcohol exposure alters cell cycle and apoptotic events during early neurulation. Alcohol and alcoholism, 43(3), 261-273. https://doi.org/10.1093/alcalc/agm166
Abd-Allah, H., Nasr, M., Ahmed-Farid, O., El-Marasy, S. A., Bakeer, R. M., & Ahmed, R. F. (2021). Biological and Pharmacological Characterization of Ascorbic Acid and Nicotinamide Chitosan Nanoparticles against Insulin-Resistance-Induced Cognitive Defects: A Comparative Study. ACS omega, 6(5), 3587-3601. https://pubs.acs.org/doi/10.1021/acsomega.0c05096
Zhong, F., Hu, Z., Jiang, K., Lei, B., Wu, Z., Yuan, G., Luo, H., Dong, C., Tang, B., Zheng, C., Yang, S., Zeng, Y., Guo, Z., Yu, S., Su, H., Zhang, G., Qiu, X., Tomlinson, S., & He, S. (2019). Complement C3 activation regulates the production of tRNA-derived fragments Gly-tRFs and promotes alcohol-induced liver injury and steatosis. Cell research, 29(7), 548-561. https://doi.org/10.1038/s41422-019-0175-2
Nakonechna, O. A., Babijchuk, L. A., & Bezrodna, A. I. (2018). Disturbance of the transmembrane phosphatidylserine asymmetry in hepatocytes as an apoptosis marker under the action of xenobiotics on rats. The Ukrainian Biochemical Journal, 90(6), 82-88. https://doi.org/10.15407/ubj90.06.082
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
